entity

PALBOCICLIB

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PALBOCICLIB: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

13Connections
0Hypotheses
1Analyses
9Outgoing
4Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (9)

TargetRelationTypeStr
CDK4/6inhibitsenzyme0.90
Motor Neuron Deathtreatsphenotype0.85
S-Phase Entryassociated_withprocess0.85
senescent glial cellscausescell_type0.70
CANCERassociated_withdisease0.45

Incoming (4)

SourceRelationTypeStr
CANCERassociated_withdisease0.45
BREAST CANCERassociated_withdisease0.45
EVEROLIMUSassociated_withdrug0.45
MTORassociated_withgene0.45

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 15 hypotheses Top: 0.822

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

Hypothesis debate: SASP-Mediated Complement Cascade Amplification

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

Related Research

Hypotheses and analyses mentioning PALBOCICLIB in their description or question text

No additional research found